Skip to content
Tenfell
Awarded contract
Published 20 Aug 2021

Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis

NHS Blood and Transplant · United Kingdom

Key facts

Contract value
£99,500
Awarded
12 Jul 2021
Contract starts
31 Jul 2021
Contract ends
31 Jul 2023
Procedure
Open procedure (above threshold)
Buyer type
Health

Awarded to

SupplierValue
Fresenius Medical Care (UK) Limited£99,500

Description

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Treatments provided include: Extracorporeal Photopheresis (ECP), Peripheral Blood Stem Cell (PBSC) Collection, Therapeutic Plasma Exchange (PEX), Red Cell Exchange (RCE), Low Density Lipid (LDL) Removal, Platelet / White Cell Depletion and Lymphocyte Collection.

The requirement for this procurement was for the supply of consumables and maintenance of the existing ART Universal machines. An opportunity notice was published on Contracts Finder on 19th March 2021 with procurement reference: tender_265689/932535

As a result of the tender, a Framework Agreement for Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis for a period of 2 years with two 1-year options to extend has been awarded to Fresenius Medical Care (UK) Ltd.

Categories (CPV)

Similar open tenders

About NHS Blood and Transplant

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.